Form 4 · Filed Apr 8, 2026, 12:00 PM UTC
KNSA/Kiniksa Pharmaceuticals International, plc
Tessari Eben — CHIEF STRATEGY OFFICER
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | M | other | 2,726 | — | — | 23,976 |
| Apr 7, 2026 | F | other | 846 | $49 | $41,403 | 23,130 |
| Apr 7, 2026 | M | other | 2,726 | $0 | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001867899-26-000004